Analysis of the pharmaceutical market of medicines with the immunomodulatory activity in Ukraine
DOI:
https://doi.org/10.24959/sphhcj.18.133Keywords:
medicines with the immunomodulatory activity, pharmaceutical market, analysis of the market, market segment, pricing tierAbstract
Aim. To conduct the analysis of the domestic pharmaceutical market of medicines with the immunomodulatory activity taking into account all their dosage forms.
Materials and Methods. The analysis was conducted on the basis of the data of the State Register of Medicines of Ukraine, the electronic database of the information retrieval routine program “Morion” and price-lists of the weekly newspaper “Pharmacy” as of April 10, 2018. Logical, system-analytical, mathematical-statistical and comparative methods of analysis were used in our work.
Results. The analysis of the domestic pharmaceutical market of medicines of the L03A group – “Immunomodulators” according to the ATC classification indicates that a large proportion of the group of medicines analyzed (approximately 58 %) is produced in Ukraine. The most popular of them are medicines in the form of a tincture (24 %) and tablets (22 %). Medicinal forms for parenteral application, in particular solutions and powders for injection, are about 36 % of the total assortment of the group. The average retail prices of medicines with the immunomodulatory activity of the L03A X group have been determined. Almost half of the packages sold (46 %) are herbal medicines. It is indicates that there is demand for this group despite their significant assortment. It has been also found that the range of herbal medicines is rather insignificant; therefore, this segment of the market consists of medicines of Echinacea Purpurea by 90 %.
Conclusions. The results of the analysis can be used when developing the new medicines with the immunomodulatory activity to expand their range and increase the availability of pharmaceutical care to patients in Ukraine.References
Mashkovskii, M. D. (2012). Lekarstvennye sredstva. 16 ed. Moscow: Novaia volna, 1216.
Fіra, L. S., Gons’kii, Ya. І. (2000). Medichna hіmіia, 1, 77–80.
Yarnyh, T. G., Dan’kevych, O. S., Leleka, M. V., Azarenko, Yu. M. (2001). Vіsnyk farmatsіi, 4 (28), 60-64.
Manscy, O. A. (2014). Justification of composition and technology of granules with sunflower protein and plant polyextract. Ukrains’kyi bіofarmatsevtychnyi zhurnal, 3, 4-7.
Mel’nyk, O. P., Ostrovs’kyi, M. M. (2015). Bukovyns’kyi medichnyi vіsnyk, 19 (4 (76)), 220-222.
Andrіichuk, Ya. R., Davtian, L. L. (2015). Farmatsevtychnyi zhurnal, 2, 20–23.
Kudryk, B. T. , Tikhonov, O. І., Bashura, O. G. (2015). Farmatsevtychnyi zhurnal, 5, 30–35.
Beniuk, V. O., Altybaieva, D. M., Goncharenko, V. M., Kurochka, V. V. (2016). Zdorov’e zhenschiny, 5 (111), 30-32.
Mnushko, Z. N., Pestun, I. V. (2008). Teoriia i praktika marketingovykh issledovanii v farmatsii.Kharkov: NFaU, 308.
Kovalenko, V. N. (Ed.). (2017). Kompendium 2016 – Lekarstvennye preparaty. Kyiv: MORION, 2270.
Derzhavnyi reiestr lіkars’kyh zasobіv. On-line versіia. Available at: http://www.moz.gov.ua/ua/portal/mtph_register_medicines/
Baza dannyh “Lekarstvennie sredstva” OOO “Morion”. Available at: www.morion.kiev.ua
Kudrik, B. Т., Tikhonov, O. I., Shpychak, О. S. (2016). Development of the composition and technology of the capsulated drug based on bee bread and honey powder. The study of pharmacotechnological properties of the mixtures of active pharmaceutical ingredients with excipients of “Api-Immuno-Vit” capsules. News of Pharmacy, 3 (87), 43–48. doi:10.24959/nphj.16.2136.
Shpychak, O. S., Tikhonov, O. І., Koval’, V. M., Bobro, S. G., Shpychak, A. O. (2017). Aktual’nі pytannia farmatsevtychnoi і medychnoi nauky ta praktyky, 10 (3 (25)), 355-363. doi: 10.14739/2409-2932.2017.3.113645.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).